Skip to main content

Table 1 Participant characteristics

From: Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation

CharacteristicDistribution
Age (years)56.7 ± 12.7
BMI (kg/m2)27.5 (5.9)
Sex
 Female9 (29.0)
 Male22 (71.0)
AF classification
 Paroxysmal25 (80.6)
 Non-paroxysmal6 (19.4)
Time since AF diagnosis (months)51.3 (53.9)
In AF during CMR scan9 (29.0)
Diabetes mellitus1 (3.2)
Ischaemic heart disease2 (6.5)
Hypertension9 (29.0)
Systolic blood pressure (mmHg)125 ± 23
Diastolic Blood pressure (mmHg)78 ± 15
LA Volume (ml)102 ± 40
minimum 47.5, maximum 195.4
LV end-diastolic volume (ml)158 ± 37
LV stroke volume (ml)93 ± 24
Cardiac output (L/min)6.3 ± 1.6
LV ejection fraction (%)59.2 ± 7.1
LV Mass (g)87.3 ± 24.7
Native T1 (ms)985 ± 35.5
LV ECV (%)24.1 ± 2.5
Mean LA pressure (mmHg)9.0 (5.0)
LA low voltage area (%)20.5 ± 7.1
ICTP (ng/ml)317.1 ± 190.1
Gal-3 (ng/ml)36.4 ± 32.9
PIIINP (pg/ml)76.4 ± 46.4
  1. AF Atrial fibrillation, BMI Body mass index, ECV Extracellular volume fraction, gal-3 Galectin 3, ICTP Type I collagen C terminal peptide, LA Left atrial, LV Left ventricular, LVEF Left ventricular ejection fraction, PIIINP Type III procollagen N terminal peptide